Compare HCM & KYIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HCM | KYIV |
|---|---|---|
| Founded | 2000 | N/A |
| Country | Hong Kong | United Arab Emirates |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 3.1B |
| IPO Year | N/A | N/A |
| Metric | HCM | KYIV |
|---|---|---|
| Price | $14.13 | $13.77 |
| Analyst Decision | Sell | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $13.75 | N/A |
| AVG Volume (30 Days) | ★ 29.0K | N/A |
| Earning Date | 08-07-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.53 | N/A |
| Revenue | ★ $602,197,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $15.54 | N/A |
| P/E Ratio | $5.26 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $11.51 | N/A |
| 52 Week High | $19.50 | N/A |
| Indicator | HCM | KYIV |
|---|---|---|
| Relative Strength Index (RSI) | 37.46 | N/A |
| Support Level | $14.11 | N/A |
| Resistance Level | $14.63 | N/A |
| Average True Range (ATR) | 0.27 | 0.00 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 21.69 | 0.00 |
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.
Kyivstar Group Ltd is engaged in mobile communication.